Skip to main content

Larson Financial Group LLC

Position in MRNA — Moderna, Inc.

CIK 1731061 ST LOUIS, MO

Position in MRNA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$110,032
+$56,066 QoQ
Shares Held
2,166
+18.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Sep 30, 2021
CallValue
$76,972
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Larson Financial Group LLC holds $4,055,906 across 194 Biotechnology names. MRNA ranks #8 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 MRNA
Moderna, Inc.
This page
2,166 $110,032

All Filings in MRNA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $110,032 2,166
2025-12-31 $53,966 1,830
2025-09-30 $55,147 2,135
2025-06-30 $68,368 2,478
2025-03-31 $73,256 2,584
2024-12-31 $52,640 1,266
2024-09-30 $60,815 910
2024-06-30 $70,418 593
2024-03-31 $3,409 32
2023-12-31 $3,182 32
2023-09-30 $11,878 115
2023-06-30 $14,944 123
2023-03-31 $18,276 119
2022-12-31 $21,374 119
2022-09-30 $14,071 119
2022-06-30 $16,999 119
2022-03-31 $19,120 111
2021-12-31 $45,970 181
2021-09-30 $76,972 200
2021-09-30 $54,265 141
2021-06-30 $23,732 101
2021-03-31 $17,940 137
2020-12-31 $13,163 126
2020-09-30 $88,720 1,254
2020-06-30 $99,653 1,552
2020-03-31 $509 17